Header Logo

Connection

Julie Schneider to Biomarkers

Back to Details
This is a "connection" page, showing publications Julie Schneider has written about Biomarkers.
Julie Schneider
Connection Strength
1.217
Biomarkers
  1. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 2023 07; 146(1):1-11.
    View in: PubMed
    Score: 0.178
  2. The time for multiple biomarkers in studies of cognitive aging and dementia is now. Neurology. 2019 03 19; 92(12):551-552.
    View in: PubMed
    Score: 0.134
  3. Vascular dysfunction-The disregarded partner of Alzheimer's disease. Alzheimers Dement. 2019 01; 15(1):158-167.
    View in: PubMed
    Score: 0.132
  4. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.128
  5. Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample. Mol Neurodegener. 2017 03 20; 12(1):26.
    View in: PubMed
    Score: 0.117
  6. Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply. Lancet Neurol. 2014 Jun; 13(6):540.
    View in: PubMed
    Score: 0.096
  7. Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol. 2014 Apr; 13(4):419-28.
    View in: PubMed
    Score: 0.095
  8. Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol. J Alzheimers Dis. 2023; 96(2):683-693.
    View in: PubMed
    Score: 0.044
  9. Vasculocentric Axonal NfH in Small Vessel Disease. J Neuropathol Exp Neurol. 2022 02 24; 81(3):182-192.
    View in: PubMed
    Score: 0.041
  10. Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology. 2019; 53(1-2):100-107.
    View in: PubMed
    Score: 0.034
  11. In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies. Neurobiol Aging. 2019 02; 74:171-181.
    View in: PubMed
    Score: 0.033
  12. Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts. PLoS Med. 2018 09; 15(9):e1002647.
    View in: PubMed
    Score: 0.032
  13. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable. Alzheimers Dement. 2018 04; 14(4):563-575.
    View in: PubMed
    Score: 0.031
  14. The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. J Neurol Neurosurg Psychiatry. 2017 11; 88(11):982-994.
    View in: PubMed
    Score: 0.030
  15. Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology. Alzheimers Dement. 2016 09; 12(9):942-951.
    View in: PubMed
    Score: 0.027
  16. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab. 2016 Apr; 36(4):819-30.
    View in: PubMed
    Score: 0.027
  17. Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
    View in: PubMed
    Score: 0.022
  18. Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm (Vienna). 2009 May; 116(5):587-97.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.